STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] ACCURAY INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Accuray Inc. (ARAY) CEO and director Stephen R. La Neve reported an open-market purchase of 20,000 shares of common stock on 11/19/2025. The transaction was reported at a weighted average purchase price of $0.9705 per share, with individual trades executed between $0.9699 and $0.9708. Following this purchase, La Neve beneficially owns 20,000 shares directly. The filing notes that detailed trade-by-trade pricing information within the stated range is available upon request.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
La Neve Stephen R.

(Last) (First) (Middle)
1240 DEMING WAY

(Street)
MADISON WI 53717

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ACCURAY INC [ ARAY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CEO
3. Date of Earliest Transaction (Month/Day/Year)
11/19/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/19/2025 P 20,000 A $0.9705(1) 20,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.9699 to $0.9708, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Remarks:
/s/ Michael Stetler, Power of Attorney for Stephen R. La Neve 11/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Accuray Inc. (ARAY) disclose in this Form 4?

Accuray Inc. disclosed that CEO and director Stephen R. La Neve bought 20,000 shares of the company’s common stock in an open-market transaction on 11/19/2025.

At what price did the Accuray (ARAY) CEO purchase shares in this filing?

The purchase was reported at a weighted average price of $0.9705 per share, with individual trades executed between $0.9699 and $0.9708.

How many Accuray (ARAY) shares does Stephen R. La Neve own after this transaction?

After the reported transaction, Stephen R. La Neve beneficially owns 20,000 shares of Accuray common stock, held directly.

What is the relationship of the reporting person to Accuray Inc. (ARAY)?

The reporting person, Stephen R. La Neve, is both a director and an officer of Accuray, serving as CEO.

Does the Form 4 explain how the Accuray (ARAY) purchase price range was determined?

Yes. The filing explains that the price in Column 4 is a weighted average and that the 20,000 shares were bought in multiple transactions between $0.9699 and $0.9708, with full breakdowns available upon request.

Is this Accuray (ARAY) Form 4 filed for one reporting person or multiple?

The form is indicated as filed by one reporting person, covering only the holdings and transaction of Stephen R. La Neve.

Accuray Incorp

NASDAQ:ARAY

ARAY Rankings

ARAY Latest News

ARAY Latest SEC Filings

ARAY Stock Data

119.01M
109.69M
2.06%
71.26%
1.97%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MADISON